These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9645664)

  • 1. 237Np: oxidation state in vivo and chelation by multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN; Allen PG; Bucher JJ; Edelstein NM; Shuh DK
    Health Phys; 1998 Jul; 75(1):34-50. PubMed ID: 9645664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New agents for in vivo chelation of uranium(VI): efficacy and toxicity in mice of multidentate catecholate and hydroxypyridinonate ligands.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Health Phys; 1997 Jun; 72(6):865-79. PubMed ID: 9169929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
    Uhlir LC; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy.
    Durbin PW; Kullgren B; Xu J; Raymond KN; Hengé-Napoli MH; Bailly T; Burgada R
    Radiat Prot Dosimetry; 2003; 105(1-4):503-8. PubMed ID: 14527018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO.
    Durbin PW; Kullgren B; Xu J; Raymond KN
    Int J Radiat Biol; 2000 Feb; 76(2):199-214. PubMed ID: 10716641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice.
    Durbin PW; Kullgren B; Ebbe SN; Xu J; Raymond KN
    Health Phys; 2000 May; 78(5):511-21. PubMed ID: 10772024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
    Durbin PW; Kullgren B; Jeung N; Xu J; Rodgers SJ; Raymond KN
    Hum Exp Toxicol; 1996 Apr; 15(4):352-60. PubMed ID: 8845226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
    Xu J; Kullgren B; Durbin PW; Raymond KN
    J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
    Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
    J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: comparison with rat, dog, and reference man.
    Durbin PW; Kullgren B; Schmidt CT
    Health Phys; 1997 Feb; 72(2):222-35. PubMed ID: 9003707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S).
    Lloyd RD; Bruenger FW; Mays CW; Atherton DR; Jones CW; Taylor GN; Stevens W; Durbin PW; Jeung N; Jones ES
    Radiat Res; 1984 Jul; 99(1):106-28. PubMed ID: 6547537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands.
    White DL; Durbin PW; Jeung N; Raymond KN
    J Med Chem; 1988 Jan; 31(1):11-8. PubMed ID: 2826783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
    Durbin PW
    Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
    Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
    Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous Chelation-Driven Reduction of the Neptunyl Cation in Aqueous Solution.
    Carter KP; Smith KF; Tratnjek T; Shield KM; Moreau LM; Rees JA; Booth CH; Abergel RJ
    Chemistry; 2020 Feb; 26(11):2354-2359. PubMed ID: 31914232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration.
    Volf V; Burgada R; Raymond KN; Durbin PW
    Int J Radiat Biol; 1996 Dec; 70(6):765-72. PubMed ID: 8980674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 3,4,3-LIHOPO for reducing neptunium retention in the rat after simulated wound contamination.
    Paquet F; Montègue B; Ansoborlo E; Hengé-Napoli MH; Houpert P; Durbin PW; Raymond KN
    Int J Radiat Biol; 2000 Jan; 76(1):113-7. PubMed ID: 10665964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the influence of chemical form and dose on absorptions of Np, Pu, Am and Cm from the gastrointestinal tracts of adult and neonatal rodents.
    Sullivan MF; Miller BM; Ruemmler PS; Ryan JL
    Health Phys; 1985 Jan; 48(1):61-73. PubMed ID: 2981787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of the multidentate hydroxypyridinonate ligand [(14) C]-3,4,3-LI(1,2-HOPO), a potent actinide decorporation agent.
    Choi TA; Endsley AN; Bunin DI; Colas C; An DD; Morales-Rivera JA; Villalobos JA; Shinn WM; Dabbs JE; Chang PY; Abergel RJ
    Drug Dev Res; 2015 May; 76(3):107-22. PubMed ID: 25857483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficiency of DTPA and other new chelating agents for removing neptunium from target organs.
    Paquet F; Metivier H; Poncy JL; Burgada R; Bailly T
    Int J Radiat Biol; 1997 May; 71(5):613-21. PubMed ID: 9191906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.